Skip to main content

KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001348911

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

13F holders, Q4 2024

Institutional positions in KalVista Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
130
+10 vs. Q3 2024
Shares held
55.2M
+6.85M (+14.2%) vs. Q3 2024
Total value
$467.4M
−$92.7M (−16.6%) vs. Q3 2024
New holders
29
50 more added
Sold out
19
29 more reduced

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 130 institutions
Q1 2021: 117 institutionsQ2 2021: 110 institutionsQ3 2021: 105 institutionsQ4 2021: 97 institutionsQ1 2022: 89 institutionsQ2 2022: 91 institutionsQ3 2022: 94 institutionsQ4 2022: 91 institutionsQ1 2023: 88 institutionsQ2 2023: 94 institutionsQ3 2023: 101 institutionsQ4 2023: 93 institutionsQ1 2024: 129 institutionsQ2 2024: 119 institutionsQ3 2024: 122 institutionsQ4 2024: 130 institutionsQ1 2025: 128 institutionsQ2 2025: 140 institutionsQ3 2025: 145 institutionsQ4 2025: 162 institutionsQ1 2026: 184 institutionsQ2 2026: 1 institution
Value heldQ4 2024: $467.4M
Q1 2021: $605.1MQ2 2021: $582.7MQ3 2021: $408.2MQ4 2021: $314.6MQ1 2022: $363.9MQ2 2022: $238.7MQ3 2022: $372.0MQ4 2022: $236.2MQ1 2023: $265.0MQ2 2023: $310.1MQ3 2023: $349.2MQ4 2023: $453.0MQ1 2024: $557.2MQ2 2024: $568.2MQ3 2024: $561.0MQ4 2024: $467.4MQ1 2025: $633.7MQ2 2025: $615.5MQ3 2025: $714.0MQ4 2025: $1.08BQ1 2026: $1.39BQ2 2026: $189
Institutions holding KALV and their total value by quarter
QuarterHoldersValue
Q2 20261$189
Q1 2026184$1.39B
Q4 2025162$1.08B
Q3 2025145$714.0M
Q2 2025140$615.5M
Q1 2025128$633.7M
Q4 2024130$467.4M
Q3 2024122$561.0M
Q2 2024119$568.2M
Q1 2024129$557.2M
Q4 202393$453.0M
Q3 2023101$349.2M
Q2 202394$310.1M
Q1 202388$265.0M
Q4 202291$236.2M
Q3 202294$372.0M
Q2 202291$238.7M
Q1 202289$363.9M
Q4 202197$314.6M
Q3 2021105$408.2M
Q2 2021110$582.7M
Q1 2021117$605.1M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q3 2024.

Institutions holding KALV in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Rosalind Advisors, Inc.303,864$2.57M1.39%00.0%Unchanged
Readystate Asset Management LP315,700$2.67M0.11%+135,700+75.4%Added
Citigroup Inc327,296$2.77M0.00%+21,792+7.1%Added
Goldman Sachs Group Inc327,673$2.78M0.00%+193,632+144.5%Added
Northern Trust Corp366,170$3.10M0.00%−13,205−3.5%Reduced
UBS Group AG374,631$3.17M0.00%+331,202+762.6%Added
Jefferies Financial Group Inc.375,000$3.18M0.04%00.0%Unchanged
Allostery Investments LP479,100$4.06M7.97%+479,100New
Emerald Mutual Fund Advisers Trust549,688$4.66M0.28%−101,292−15.6%Reduced
Saturn V Capital Management LLC556,489$4.71M1.85%00.0%Unchanged
Silverarc Capital Management, LLC612,173$5.19M1.16%+37,615+6.5%Added
Dimensional Fund Advisors LP696,037$5.90M0.00%+89,001+14.7%Added
Schroder Investment Management Group805,445$6.76M0.01%+374,213+86.8%Added
DAFNA Capital Management LLC811,678$6.87M1.75%+88,000+12.2%Added
Geode Capital Management, LLC822,352$6.97M0.00%−8,632−1.0%Reduced
Emerald Advisers, LLC836,050$7.08M0.27%+620.0%Added
StemPoint Capital LP992,803$8.41M2.11%+992,803New
Woodline Partners LP1,288,401$10.9M0.07%+680,148+111.8%Added
Octagon Capital Advisors LP1,370,000$11.6M1.98%+1,370,000New
State Street Corp1,390,863$11.8M0.00%+119,254+9.4%Added
Boxer Capital Management, LLC1,590,000$13.5M1.15%+1,590,000New
Great Point Partners LLC1,787,003$15.1M7.13%+487,500+37.5%Added
Vanguard Group Inc2,255,243$19.1M0.00%+104,716+4.9%Added
BlackRock, Inc.2,863,996$24.3M0.00%−198,323−6.5%Reduced
Capital World Investors3,374,064$28.6M0.00%00.0%Unchanged
Vestal Point Capital, LP4,770,000$40.4M2.40%+770,000+19.3%Added
Frazier Life Sciences Management, L.P.4,887,867$41.4M1.72%+1,200,000+32.5%Added
Tang Capital Management LLC4,893,847$41.5M2.74%+572,300+13.2%Added
Suvretta Capital Management, LLC4,913,012$41.6M1.54%+701,007+16.6%Added
VR Adviser, LLC6,249,731$52.9M3.63%00.0%Unchanged
Boxer Capital, LLC0$00.00%−1,590,000−100.0%Sold out
MPM Oncology Impact Management LP0$00.00%−896,915−100.0%Sold out
First Turn Management, LLC0$00.00%−355,000−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−26,968−100.0%Sold out
Squarepoint Ops LLC0$00.00%−25,749−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−22,949−100.0%Sold out
Susquehanna Portfolio Strategies, LLC0$00.00%−18,338−100.0%Sold out
Paloma Partners Management Co0$00.00%−17,924−100.0%Sold out
Deerfield Management Company, L.P. (Series C)0$00.00%−13,255−100.0%Sold out
AQR Capital Management LLC0$00.00%−12,354−100.0%Sold out
Healthcare of Ontario Pension Plan Trust Fund0$00.00%−4,500−100.0%Sold out
Venturi Wealth Management, LLC0$00.00%−410−100.0%Sold out
nVerses Capital, LLC0$00.00%−200−100.0%Sold out
Red Tortoise LLC0$00.00%−187−100.0%Sold out
Bessemer Group Inc0$00.00%−45−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−39−100.0%Sold out
Creekmur Asset Management LLC0$00.00%−23−100.0%Sold out
Fortitude Family Office, LLC0$00.00%−3−100.0%Sold out
National Bank of Canada0$00.00%−1−100.0%Sold out
ClariVest Asset Management LLC––––Not filed
PEAK6 Investments LLC––––Not filed